Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A value-driven, catalyst-led small-cap approach is drawing attention as investors seek mispriced names with clear ups...
Crypto hedge funds started 2026 with losses as volatility rose, prompting a shift to market-neutral and relative-valu...
A fresh model built on bitcoin cycle data projects forecasts a pronounced downside path for BTC, with a December 2026...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
Chevron announces a quarterly dividend of $1.78 per share, marking 39 years of uninterrupted growth. Q4 results show ...
As the Fed signals potential rate cuts, long-duration growth names with strong cash flows could re-rate. This piece f...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...
GRNY beats COWZ by 11 points this year, signaling a tilt toward AI, electrification, and energy themes. Oil prices an...
FuelCell Energy leads a hydrogen stock rebound with a 15% jump as investors chase AI data center exposure. Bloom Ener...